NO. |
PRODUCT
NAME |
|
API name |
61 |
3,5-Bis(2-cyanoprop-2-yl)toluene |
120511-72-0 |
Anastrozole |
62 |
2,2-Dimethyl Butyryl Chloride |
5856-77-9 |
Simvastatin |
63 |
1,2,3- triacetoxy -5-deoxy-D-ribose |
62211-93-2 |
Capecitabine |
64 |
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
Capecitabine |
65 |
(3aR,4S,7R,7aS)4,7-Methano-1H-isoindole-1,3(2H)-dione |
14805-29-9 |
Lurasidone |
66 |
(1R,2R)-1,2-Bis(methanesulfonyloxymethyl) cyclohexane |
186204-35-3 |
Lurasidone |
67 |
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)Thio]Nonyl]-Estra-1,3,5(10)-Triene-3,17-Diol 17-Acetate |
875573-69-6 |
Fulvestrant |
68 |
(7a,17b)-7-(9-Bromononyl)-Estra-1,3,5(10)-Triene-3,17-Diol 17-Acetate |
875573-66-3 |
Fulvestrant |
69 |
Boc-(R)-3-Amino-4-(2,4,5-trifluo-rophenyl)butanoic acid |
486460-00-8 |
Sitagliptin Phosphate |
70 |
2-Fluoro-2',3',5'-triacetoxyadenosine |
15811-32-2 |
Fludarabine Phosphate |
71 |
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one |
199327-61-2 |
Gefitinib |
72 |
N-[3-Chloro-4-(3-Fluorobenzyloxy)-Phenyl]-6-Iodoquinazolin-4-Amine |
231278-20-9 |
Lapatinib |
73 |
2-(Methylsulfonyl) Ethylamine HCL |
104458-24-4 |
Lapatinib |
74 |
6-benzyloxy guanine 2-amino-6-benzyloxypurine |
19916-73-5 |
Entecavir |
75 |
4,6-dichloro-2-propylthiopyrimidine-5-amine |
145783-15-9 |
Ticagrelor |
76 |
Abiraterone base |
154229-19-3 |
Abiraterone acetate |
77 |
5'-deoxy-2', 3'-O-isopropylidene -5-fluorouridine |
66335-39-5 |
Doxifluridine |
78 |
2-acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate |
162358-09-0 |
Fingolimod |
79 |
Diethyl 2-acetamido-2-(4-octylphenethyl)malonate |
162358-08-9 |
Fingolimod |
80 |
(R)-BoroLeu-(+)-Pinanediol-CF3COOH |
179324-87-9 |
Bortezomib |
81 |
5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
3543-74-6 |
Bendamustine HCl |
82 |
Boc-3-Hydroxy-1-adamantyl-D-glycine |
361442-00-4 |
Saxagliptin |
83 |
(2b,3a,16b,17b)-2,16-Bispiperidino-3,17-diacetoxy-5-androstane |
13529-31-2 |
Vecuronim Bromide |
* The products under valid patents will not be offered to the
countries covered by the patents.